Stay updated with breaking news from Beth Kurth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leuven, BELGIUM, Boston, MA, US - MAY 24, 2022 - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies,
Investegate announcements from Oxurion NV, Oxurion Announces Top-Line Results from Part A of Phase 2 INTEGRAL Trial Evaluating THR-687 for Treatment of Diabetic Macular Edema (DME)
Leuven, Belgium, Boston, MA, US - May 6, 2022 - 07.00 PM CET - Oxurion NV(Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation
Investegate announcements from Oxurion NV, Oxurion Announces Results of the Extraordinary and Annual Shareholders’ Meetings of 3 May 2022 and Invitation to the Extraordinary Shareholders’ Meeting of 24 May 2022
Leuven, BELGIUM, Boston, MA, US - May 3, 2022 - 7:10 PM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies